Plain-English translation of NCT07890337 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
ReVIVE is a clinical trial testing a new approach to help veterans recover from mild traumatic brain injuries (concussions) and trauma-related stress. The study combines virtual reality therapy with standard care—like talk therapy and medications you may already be receiving—to see if the combination helps people regain focus, manage stress responses, and return to daily activities more successfully.
Many veterans struggle with ongoing symptoms after concussions, including trouble concentrating and feeling constantly on alert. This trial exists because researchers believe that virtual reality—which lets people practice coping skills in safe, controlled situations—might help these symptoms better than treatment alone.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to either receive six weekly virtual reality sessions (in addition to your regular therapy and medications) or to continue with your standard care alone. Each virtual reality session lasts about 40 minutes total—10 minutes to get comfortable with the technology, then 30 minutes of immersive activities designed to help you practice relaxation and coping skills in realistic everyday scenarios. The researchers will also check in with you about any discomfort from the virtual reality experience.
AI-generated summary from trial data · Oct 27, 2026 · Not medical advice
United States